State Street’s XLV offers low-cost exposure to established healthcare firms, while Simplify’s PINK targets high-growth medical innovation with active management.
Two healthcare ETFs cater to distinct investor preferences: the State Street Health Care Select Sector SPDR ETF (XLV) and the Simplify Health Care ETF (PINK). XLV provides passive, low-cost exposure to 60 S&P 500 healthcare giants, including Eli Lilly and Johnson & Johnson, with a 0.08% expense ratio and a 1.70% dividend yield.
PINK, in contrast, employs an active strategy led by portfolio manager Michael Taylor, focusing on medical breakthroughs in biotech and medtech. Its 0.51% expense ratio and lower 0.66% yield reflect its growth-oriented approach, targeting higher-risk, high-reward opportunities.
The funds’ differing philosophies—stability versus innovation—offer investors a choice between established sector leaders and emerging disruptors.